Noam Solomon (L) and Luis Voloch, Immunai co-founders
Koch leads mammoth $215M infusion into AI startup boasting 'largest database' of immune cells
In the three years since Noam Solomon and Luis Voloch started Immunai, the company has quickly outgrown its digs.
Immunai’s team went from 30 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
